Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

NCT00048451 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00048451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00048451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2002
Completion date
Not reported
Enrollment
68
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

renal insufficiency, chronic